Clinical trial
Pan-genome Sequencing of Urine Cell-free DNA for Therapy of Urinary Infectious Diseases: a Single Center Prospective Study Clinical Control Study
NCT05624476 is registered in ClinicalTrials.gov with Shanghai Changzheng Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pan-genome Sequencing of Urine Cell-free DNA for Therapy of Urinary Infectious Diseases: a Single Center Prospective Study Clinical Control Study
- Lead sponsor
- Shanghai Changzheng Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2023
- Completion date
- December 31, 2023
- Enrollment
- 72 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
sequelae of; infection, urinary tract infections